ABO blood group system B, and AB blood into type O. This is done by using glycosidase enzymes from specific bacteria to strip the blood group antigens from red blood cells. The removal of A and B antigens still does not address the problem of the Rh blood group antigen on the blood cells of Rh positive individuals, and so blood from Rh negative donors must be used. Patient trials will be conducted before the method can be relied on in live situations. Another approach to the blood antigen problem is the manufacture of artificial blood, which could act as a substitute in emergencies.
Blood type transfusion can be considered safe as long as the serum of the recipient does not contain antibodies for the blood cell antigens of the donor. The "ABO system" is the most important blood-group system in human-blood transfusion. The associated anti-A and anti-B antibodies are usually "immunoglobulin M", abbreviated IgM, antibodies. ABO IgM antibodies are produced in the first years of life by sensitization to environmental substances such as food, bacteria, and viruses. The original terminology used by Karl Landsteiner in 1901 for the classification was A/B/C; in later publications "C" became "O". Type O is often called "0" ("zero", or